Exploring How ESR1 Inhibitors Can Improve Your Treatment Success
ESR1 inhibitors are emerging as a pivotal treatment for hormone receptor-positive breast cancer, particularly in cases resistant to standard therapies. By targeting mutations in the estrogen receptor gene, these drugs, including selective estrogen receptor degraders, offer promising advancements in patient outcomes. Explore the latest clinical trials and understand the transformative potential of ESR1 inhibitors in […]
3 minute read